Stephen Patek is currently the Director of Algorithm Engineering at Dexcom, focusing on Therapeutics, Diagnostics, and Insights. As a co-inventor of the artificial pancreas algorithm embedded in Control-IQ, Stephen has significantly improved the lives of individuals with type 1 diabetes. They co-founded TypeZero Technologies, serving as Vice President of R&D until its acquisition by Dexcom, and hold 15 US patents in various technical areas. Previously, Stephen was a full professor at the University of Virginia's School of Engineering and Applied Science, where they taught hundreds of students and contributed to numerous research publications. Stephen earned a Ph.D. in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology, along with a Master’s Degree in the same field and a Bachelor’s Degree in Electrical Engineering from the University of Tennessee, Knoxville.
This person is not in the org chart
This person is not in any teams
This person is not in any offices